Transseptal Solutions Business
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target Customer
Healthcare & Life SciencesHealthcareProviders
Core Technology
Materials & Substances
Tags (5)
cardiologymedical-technologiesvalvessurgeonsmedical-devices
Transseptal Solutions Financials
Transseptal Solutions Lifecycle
Transseptal Solutions News
4 articles
Safe access to the left atrium is crucial for each treatment. Physicians can choose from a variety of fixed sheaths to bidirectional deflectable sheaths, together with the corresponding needles for transseptal puncture.
The article discusses the various medical tools and solutions provided by Merit Medical for the treatment of arrhythmia. These include a variety of fixed sheaths to bidirectional deflectable sheaths, together with the corresponding needles for transseptal puncture. The companys products such as the Senovo Bi-Flex Deflectable Transseptal Sheath, Adnovo MAX 2.0, HeartSpan® Fixed Curve Transseptal Sheath, and HeartSpan® Needle are mentioned.
None
Transseptal Solutions Announces First Clinical Use of TSP Crosser™ in the United States
Transseptal Solutions Ltd. announced the completion of the first TSP Crosser transseptal puncture procedure in the US. The procedure was successfully performed by Dr. Latib at Montefiore-Einstein Center for Heart and Vascular Care. The TSP Crosser is an innovative device that facilitates safe and accurate transseptal puncture. The company is excited to launch its activity in the US and is honored to work with Montefiores structural heart interventions team. The TSP Crosser is an advanced transseptal puncture system with a built-in steering mechanism, indicated for use in various procedures. Transseptal Solutions aims to improve the left atrium access procedure and serve the expanding indications of left heart treatment.
Customers
Transseptal Solutions Announces First Clinical Use of TSP Crosser™ in the United States
Transseptal Solutions Ltd., an Israel-based medical device company, announced the successful completion of the first TSP Crosser transseptal puncture procedure in the US. The procedure was performed at the Montefiore-Einstein Center for Heart and Vascular Care. The TSP Crosser is a device that facilitates safe, accurate, and reproducible transseptal puncture. The companys CEO, Elad Sapir, described the US launch as a major milestone for the company.
Customers
FDA clears Transseptal Solutions' TP Crosser transseptal access device
Transseptal Solutions has received FDA 510(k) clearance for its TSP Crosser transseptal access system. The system is designed for use in accessing the left atrium during procedures such as mitral valve repair and replacement. The TSP Crosser features a built-in steering mechanism and a flexible puncturing needle for precise and controlled transseptal puncture. The device has already received CE Mark approval in the European Union. The FDA clearance is expected to meet the growing global demand for trans-septal catheter intervention for patients with structural heart disease.
CustomersPartners
Transseptal Solutions Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 2 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 7 classification IDs that could be used for matching.
